This study focuses on the development of a 3-dimensional porous scaffold using Polycaprolactone/Gelatin/Nanoclay (PCL/GNF/NC) for bone tissue engineering. The scaffold incorporates varying dosages of silybin (Sil) through a mixture of electrospinning and thermal-induced phase separation (TIPS) techniques. Assessments of surface shape, porosity, compressive strength, water contact angle, degradation rate, releasing profile, hemolysis, and cell proliferation were among the investigations carried out to appraise the manufactured scaffolds. In vivo evaluation utilized a rat calvaria defect model, with histological analysis employed to assess the results. The scaffolds exhibited porosity within the range of 70-90%, and those containing silybin demonstrated lower compressive strength and contact angle, along with a higher degradation rate compared to those without silybin. Release experiments revealed a 61.09% release of silybin after 28 days. In both in vivo and in vitro assessments, the PCL/GNF/NC/Sil1% scaffold displayed superior cell proliferation and bone healing properties compared to other groups. These findings suggest the potential efficacy of silybin in bone defect treatment, warranting further investigation in future research.
AnnamalaiRTHongXSchottNG, et al.Injectable osteogenic microtissues containing mesenchymal stromal cells conformally fill and repair critical-size defects. Biomaterials2019; 208: 32–44.
2.
SchemitschEH. Size matters: defining critical in bone defect size. J Orthop Trauma2017; 31: S20–S22.
3.
McDermottAMHerbergSMasonDE, et al.Recapitulating bone development through engineered mesenchymal condensations and mechanical cues for tissue regeneration. Sci Transl Med2019; 11(495): eaav7756.
4.
GreshamRCBahneyCSLeachJK. Growth factor delivery using extracellular matrix-mimicking substrates for musculoskeletal tissue engineering and repair. Bioact Mater2021; 6(7): 1945–1956.
5.
DingTKangWLiJ, et al.An in situ tissue engineering scaffold with growth factors combining angiogenesis and osteoimmunomodulatory functions for advanced periodontal bone regeneration. J Nanobiotechnol2021; 19: 247.
6.
HayrapetyanAJansenJAvan den BeuckenJJ. Signaling pathways involved in osteogenesis and their application for bone regenerative medicine. Tissue Eng Part B2014; 21(1): 75–87.
7.
SherwoodJMonkhouseDGayloC. Complex three-dimensional composite scaffold resistant to delimination. Mountain View, California: Google Patents, 2003.
8.
DuconseilleAAstrucTQuintanaN, et al.Gelatin structure and composition linked to hard capsule dissolution: a review. Food Hydrocoll2015; 43: 360–376.
9.
TvlHBVidyavathiMKavithaK, et al. Preparation and evaluation of ciprofloxacin loaded chitosan-gelatin composite films for wound healing activity. Int J Drug Deliv2010; 2(2).
10.
BagherZAtoufiZAlizadehR, et al.Conductive hydrogel based on chitosan-aniline pentamer/gelatin/agarose significantly promoted motor neuron-like cells differentiation of human olfactory ecto-mesenchymal stem cells. Mater Sci Eng C2019; 101: 243–253.
11.
ZamaniSRezaei kolarijaniNNaeijiM, et al.Development of carboxymethyl cellulose/gelatin hydrogel loaded with Omega-3 for skin regeneration. J Biomater Appl2024; 39(4): 377–395.
12.
MajiKDasguptaSPramanikK, et al.Preparation and evaluation of gelatin-chitosan-nanobioglass 3D porous scaffold for bone tissue engineering. Int J Biomater2016; 2016: 9825659.
13.
CórdobaLJPSobralPJ. Physical and antioxidant properties of films based on gelatin, gelatin-chitosan or gelatin-sodium caseinate blends loaded with nanoemulsified active compounds. J Food Eng2017; 213: 47–53.
14.
TangYZhouYLanX, et al.Electrospun gelatin nanofibers encapsulated with peppermint and chamomile essential oils as potential edible packaging. J Agric Food Chem2019; 67(8): 2227–2234.
15.
FarzamfarSNaseri-NosarMSahrapeymaH, et al.Tetracycline hydrochloride-containing poly (ε-caprolactone)/poly lactic acid scaffold for bone tissue engineering application: in vitro and in vivo study. International Journal of Polymeric Materials and Polymeric Biomaterials2019; 68(8): 472–479.
16.
MiddletonJCTiptonAJ. Synthetic biodegradable polymers as orthopedic devices. Biomaterials2000; 21: 2335–2346.
17.
GuptaDVenugopalJMitraS, et al.Nanostructured biocomposite substrates by electrospinning and electrospraying for the mineralization of osteoblasts. Biomaterials2009; 30(11): 2085–2094.
18.
Al-BaadaniMAHii Ru YieKAl-BishariAM, et al.Co-electrospinning polycaprolactone/gelatin membrane as a tunable drug delivery system for bone tissue regeneration. Mater Des2021; 209: 109962.
19.
RenKWangYSunT, et al.Electrospun PCL/gelatin composite nanofiber structures for effective guided bone regeneration membranes. Mater Sci Eng C2017; 78: 324–332.
20.
ZhaoZZhengJWangM, et al.High performance ultrafiltration membrane based on modified chitosan coating and electrospun nanofibrous PVDF scaffolds. J Membr Sci2012; 394-395: 209–217.
21.
GautamSPurohitSDSinghH, et al.Surface modification of PCL-gelatin-chitosan electrospun scaffold by nano-hydroxyapatite for bone tissue engineering. Mater Today Commun2023; 34: 105237.
22.
ArmentanoIDottoriMFortunatiE, et al.Biodegradable polymer matrix nanocomposites for tissue engineering: a review. Polym Degrad Stabil2010; 95(11): 2126–2146.
23.
JousseinEPetitSChurchmanJ, et al.Halloysite clay minerals—a review. Clay Miner2005; 40(4): 383–426.
24.
NityaGNairGTMonyU, et al.In vitro evaluation of electrospun PCL/nanoclay composite scaffold for bone tissue engineering. J Mater Sci Mater Med2012; 23(7): 1749–1761.
25.
VergaroVAbdullayevELvovYM, et al.Cytocompatibility and uptake of halloysite clay nanotubes. Biomacromolecules2010; 11(3): 820–826.
26.
VergaroVAbdullayevEZeitounA, et al.Halloysite clay nanotubes: characterization, biocompatibility and use as drug carriers. J Microencapsul2008; 25: 376.
27.
NazariSNaeimiMRafieniaM, et al.Fabrication and characterization of 3D nanostructured polycaprolactone-gelatin/nanohydroxyapatite-nanoclay scaffolds for bone tissue regeneration. J Polym Environ2024; 32(1): 94–110.
28.
XiangHDaiXXuW, et al.Cryogenic 3D printing of bifunctional silicate nanoclay incorporated scaffolds for promoted angiogenesis and bone regeneration. Mater Des2022; 223: 111220.
29.
BorsariMGabbiCGhelfiF, et al.Silybin, a new iron-chelating agent. J Inorg Biochem2001; 85(2-3): 123–129.
30.
KřenVWalterováD. Silybin and silymarin-new effects and applications. Biomed papers2005; 149(1): 29–41.
31.
TaoZLiT-LYangM, et al.Silibinin can promote bone regeneration of selenium hydrogel by reducing the oxidative stress pathway in ovariectomized rats. Calcif Tissue Int2022; 110(6): 723–735.
32.
HashemiSFMehrabiMEhteramiA, et al.In-vitro and in-vivo studies of PLA/PCL/gelatin composite scaffold containing ascorbic acid for bone regeneration. J Drug Deliv Sci Technol2021; 61: 102077.
33.
ZamaniSSalehiMAbbaszadeh-GoudarziG, et al.Evaluation effect of alginate hydrogel containing losartan on wound healing and gene expression. J Biomater Appl2025: 08853282241292144.
34.
SemyariHSalehiMTaleghaniF, et al.Fabrication and characterization of collagen–hydroxyapatite-based composite scaffolds containing doxycycline via freeze-casting method for bone tissue engineering. J Biomater Appl2018; 33(4): 501–513.
35.
NaghiehSBadrossamayMForoozmehrE, et al.Combination of PLA micro-fibers and PCL-gelatin nano-fibers for development of bone tissue engineering scaffolds. Int J Swarm Intell Evol Comput2017; 6(1): 1–4.
36.
SuchýTŠupováMBartošM, et al.Dry versus hydrated collagen scaffolds: are dry states representative of hydrated states?J Mater Sci Mater Med2018; 29(2): 20.
37.
Ranjbar-MohammadiMBahramiSH. Development of nanofibrous scaffolds containing gum tragacanth/poly (ε-caprolactone) for application as skin scaffolds. Mater Sci Eng C2015; 48: 71–79.
38.
KolarijaniNRMirzaiiMZamaniS, et al.Assessment of the ability of Pseudomonas aeruginosa and Staphylococcus aureus to create biofilms during wound healing in a rat model treated with carboxymethyl cellulose/carboxymethyl chitosan hydrogel containing EDTA. Int Wound J2024; 21(5): e14878.
39.
ZamaniSSalehiMEhteramiA, et al.Assessing the efficacy of curcumin-loaded alginate hydrogel on skin wound healing: a gene expression analysis. J Biomater Appl2024; 38(9): 957–974.
40.
EsmaeiliSRahmatiMZamaniS, et al.A comparison of several separation processes for eggshell membrane powder as a natural biomaterial for skin regeneration. Skin Res Technol2024; 30(9): e70038.
41.
SoleimaniMNadriS. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc2009; 4(1): 102–106.
42.
DíazLZambranoEFloresME, et al.Ethical considerations in animal research: the principle of 3R's. Rev Invest Clin2021; 73(4): 199–209.
43.
ToumajNSalehiMZamaniS, et al.Development of alginate/chitosan hydrogel loaded with obestatin and evaluation of collagen type I, III, VEGF and TGF‐β1 gene expression for skin repair in a rat model (in vitro and in vitro study). Skin Res Technol2024; 30(8): e70018.
44.
WangXXuSZhouS, et al.Topological design and additive manufacturing of porous metals for bone scaffolds and orthopaedic implants: a review. Biomaterials2016; 83: 127–141.
45.
RibeiroCPanaderoJSencadasV, et al.Fibronectin adsorption and cell response on electroactive poly (vinylidene fluoride) films. Biomed Mater2012; 7(3): 035004.
46.
de SousaMBMF. Development and characterization of poly (lactic acid)/fish gelatine electrospun membranes for peripheral nerve regeneration. 2016.
47.
CalligarisSComuzzoPBotF, et al.Nanoemulsions as delivery systems of hydrophobic silybin from silymarin extract: effect of oil type on silybin solubility, in vitro bioaccessibility and stability. LWT-Food science and technology2015; 63(1): 77–84.
48.
KhoshnevisanKMalekiHSamadianH, et al.Antibacterial and antioxidant assessment of cellulose acetate/polycaprolactone nanofibrous mats impregnated with propolis. Int J Biol Macromol2019; 140: 1260–1268.
49.
LabetMThielemansW. Synthesis of polycaprolactone: a review. Chem Soc Rev2009; 38(12): 3484–3504.
50.
WoodruffMAHutmacherDW. The return of a forgotten polymer—polycaprolactone in the 21st century. Prog Polym Sci2010; 35(10): 1217–1256.
51.
KimMSJunIShinYM, et al.The development of genipin‐crosslinked poly (caprolactone)(PCL)/gelatin nanofibers for tissue engineering applications. Macromol Biosci2010; 10(1): 91–100.
52.
FayyazbakhshFSolati-HashjinMKeshtkarA, et al.Novel layered double hydroxides-hydroxyapatite/gelatin bone tissue engineering scaffolds: fabrication, characterization, and in vivo study. Mater Sci Eng C2017; 76: 701–714.
53.
HoddeJ. Naturally occurring scaffolds for soft tissue repair and regeneration. Tissue Eng2002; 8(2): 295–308.
54.
LiuXSmithLAHuJ, et al.Biomimetic nanofibrous gelatin/apatite composite scaffolds for bone tissue engineering. Biomaterials2009; 30(12): 2252–2258.
55.
HwangHSLeeC-S. Nanoclay-composite hydrogels for bone tissue engineering. Gels2024; 10(8): 513.
56.
FuruichiTHiraiHKitaharaT, et al.Nanoclay gels attenuate BMP2-associated inflammation and promote chondrogenesis to enhance BMP2-spinal fusion. Bioact Mater2025; 44: 474–487.
57.
NishaABhardwajRVermaM, et al.Functionalized nanoclays in bioactive materials. Compos Interfaces2024; 31(7): 857–881.
58.
YaoQFuglsbyKEZhengX, et al.Nanoclay-functionalized 3D nanofibrous scaffolds promote bone regeneration. J Mater Chem B2020; 8(17): 3842–3851.
59.
IslamAMishraASiddiquiMA, et al. Recapitulation of evidence of phytochemical, pharmacokinetic and biomedical application of silybin. 9th ed.. Drug Research, 2021, 71, pp. 489–503.
60.
OufiHG. The cytogenetic effects of silibinin alone and in combination with methotrexate in mouse bone marrow. Eur J Pharmacol2018; 824: 179–184.
61.
HosseinkhaniHHosseinkhaniMTianF, et al.Bone regeneration on a collagen sponge self-assembled peptide-amphiphile nanofiber hybrid scaffold. Tissue Eng2007; 13(1): 11–19.
62.
LiuXMaPX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng2004; 32(3): 477–486.
63.
LiJJKaplanDLZreiqatH. Scaffold-based regeneration of skeletal tissues to meet clinical challenges. J Mater Chem B2014; 2(42): 7272–7306.
64.
WangLChenQYarlagaddaPK, et al.Single-parameter mechanical design of a 3D-printed octet truss topological scaffold to match natural cancellous bones. Mater Des2021; 209: 109986.
65.
YazdanpanahZJohnstonJDCooperDM, et al.3D bioprinted scaffolds for bone tissue engineering: state-of-the-art and emerging technologies. Front Bioeng Biotechnol2022; 10: 824156.
66.
LeeSSDuXKimI, et al.Scaffolds for bone-tissue engineering. Matter2022; 5(9): 2722–2759.
67.
ChinnasamiHDeyMKDevireddyR. Three-dimensional scaffolds for bone tissue engineering. Bioengineering2023; 10(7): 759.
68.
DoyleMEDalgarnoKMasoeroE, et al.Advances in biomimetic collagen mineralisation and future approaches to bone tissue engineering. Biopolymers2023; 114(1): e23527.
69.
Buer BoyeteyMJTorgboSSukyaiP. Bio-scaffold for bone tissue engineering with focus on bacterial cellulose, biological materials for hydroxyapatite synthesis and growth factors. Eur Polym J2023; 194: 112168.
70.
SabirMIXuXLiL. A review on biodegradable polymeric materials for bone tissue engineering applications. J Mater Sci2009; 44(21): 5713–5724.
71.
WangHZhangYRenC, et al.Biomechanical properties and clinical significance of cancellous bone in proximal femur: a review. Injury2023; 54(6): 1432–1438.
72.
Van AudekerckeRMartensM. Mechanical properties of cancellous bone. Natural and living biomaterials2018, pp. 89–98.
73.
HenkelmanSRakhorstGBlantonJ, et al.Standardization of incubation conditions for hemolysis testing of biomaterials. Mater Sci Eng C2009; 29(5): 1650–1654.
74.
DudaGNGeisslerSChecaS, et al.The decisive early phase of bone regeneration. Nat Rev Rheumatol2023; 19(2): 78–95.
75.
GillmanCEJayasuriyaAC. FDA-approved bone grafts and bone graft substitute devices in bone regeneration. Mater Sci Eng C2021; 130: 112466.
76.
YangNLiuY. The role of the immune microenvironment in bone regeneration. Int J Med Sci2021; 18(16): 3697–3707.
77.
BattafaranoGRossiMDe MartinoV, et al.Strategies for bone regeneration: from graft to tissue engineering. Int J Mol Sci2021; 22(3): 1128.
78.
CanceddaR. Cartilage and bone extracellular matrix. Curr Pharm Des2009; 15(12): 1334–1348.
79.
FernandesHMoroniLVan BlitterswijkC, et al.Extracellular matrix and tissue engineering applications. J Mater Chem2009; 19(31): 5474–5484.
80.
ŠkoloudíkLChrobokVKočíZ, et al.The transplantation of hBM-MSCs increases bone neo-formation and preserves hearing function in the treatment of temporal bone defects–on the experience of two month follow up. Stem Cell Rev Rep2018; 14(6): 860–870.
81.
SalehiMAiAEhteramiA, et al.In vitro and in vivo Investigation of poly (lactic acid)/hydroxyapatite nanoparticle scaffold containing nandrolone decanoate for the regeneration of critical-sized bone defects. Nanomedicine Journal2020; 7(2): 115–123.
